Skip to main content

Table 2 Growth inhibition induced by transformed compounds against human lung cancer cell line (NCI-H460)

From: In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of Dianabol through Azadirachta indica and its molecular docking studies

Compound(s)

GI50(μM)

TGI (μM)

1

28.3 ± 2.72

NDa

2

22.5 ± 4.15

60 ± 9.2

3

ND

ND

Doxorubicin (control)

0.08 ± 0.02

---

  1. aND: Values could not be determined indicates <50% inhibition of cell growth at maximum dose (100 μM) tested.